MIGARD

This brand name is authorized in Estonia, Finland, Lithuania, United Kingdom

Active ingredients

The drug MIGARD contains one active pharmaceutical ingredient (API):

1 Frovatriptan UNII D28J6W18HY - FROVATRIPTAN SUCCINATE

Frovatriptan is a selective agonist for 5-HT receptors. Frovatriptan is believed to act selectively on extracerebral, intracranial arteries to inhibit the excessive dilatation of these vessels in migraine. Read about Frovatriptan

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MIGARD Film-coated tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N02CC07	Frovatriptan	N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CC Selective serotonin (5HT1) agonists
Discover more medicines within N02CC07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1161537, 1161548, 1161559, 1161560, 1161571, 1161582, 1161593
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 019808, 020027, 020053
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 43642
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1016988, 1016989, 1016990, 1016991, 1016992, 1016993